Cygnal Therapeutics Stock

Cygnal Therapeutics is a biotechnology company

Sign up today and learn more about Cygnal Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Cygnal Therapeutics Stock

Cygnal Therapeutics is developing drugs to manipulate Exoneural Biology for the treatment of cancer, immunological diseases, and regenerative processes. Powered by a comprehensive, cutting-edge neurotechnology platform, They are discovering new dimensions of neural function. Cygnal was founded by Flagship Pioneering in the VentureLabs innovation foundry.

Investors

Funding History

October 2019$65.0M

Management

Principal / Co-Founder, Flagship Pioneering / Cygnal Therapeutics

Jordi Mata-Fink

Partner / Founding President & CEO, Flagship Pioneering / Cygnal Therapeutics

Avak Kahvejian

Chief Medical Officer

John Wagner

VP Bioinformatics

Hongyue Dai

Founder and CEO / Founding Chairman, Flagship Pioneering / Cygnal Therapeutics

Noubar Afeyan

Chief Business Officer

Elaine Caughey

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo